{"id":"https://openalex.org/W2056464571","doi":"https://doi.org/10.1016/s0378-5173(01)00656-1","title":"In vitro release of dexmedetomidine from silica xerogel monoliths: effect of sol-gel synthesis parameters","display_name":"In vitro release of dexmedetomidine from silica xerogel monoliths: effect of sol-gel synthesis parameters","publication_year":2001,"publication_date":"2001-06-01","ids":{"openalex":"https://openalex.org/W2056464571","doi":"https://doi.org/10.1016/s0378-5173(01)00656-1","mag":"2056464571","pmid":"https://pubmed.ncbi.nlm.nih.gov/11397572"},"language":"en","primary_location":{"id":"doi:10.1016/s0378-5173(01)00656-1","doi":"https://doi.org/10.1016/s0378-5173(01)00656-1","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0378-5173(01)00656-1","pdf_url":null,"source":{"id":"https://openalex.org/S131016564","display_name":"International Journal of Pharmaceutics","issn_l":"0378-5173","issn":["0378-5173","1873-3476"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Pharmaceutics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5032586507","display_name":"Pirjo Kortesuo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210118237","display_name":"Orion Corporation (Finland)","ror":"https://ror.org/0296s4x19","country_code":"FI","type":"company","lineage":["https://openalex.org/I4210118237"]}],"countries":["FI"],"is_corresponding":true,"raw_author_name":"Pirjo Kortesuo","raw_affiliation_strings":["Pharmaceutical Development Department, Orion Pharma, Orion Corporation, P.O. Box 425, 20101 Turku, Finland. pirjo.kortesuo@orionpharma.com","Pharmaceutical Development Department, Orion Pharma, Orion Corporation, P.O. Box 425, 20101 Turku, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Development Department, Orion Pharma, Orion Corporation, P.O. Box 425, 20101 Turku, Finland. pirjo.kortesuo@orionpharma.com","institution_ids":["https://openalex.org/I4210118237"]},{"raw_affiliation_string":"Pharmaceutical Development Department, Orion Pharma, Orion Corporation, P.O. Box 425, 20101 Turku, Finland","institution_ids":["https://openalex.org/I4210118237"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082028304","display_name":"Manja Ahola","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I155660961","display_name":"University of Turku","ror":"https://ror.org/05vghhr25","country_code":"FI","type":"education","lineage":["https://openalex.org/I155660961"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Manja Ahola","raw_affiliation_strings":["Institute of Dentistry, University of Turku, Lemmink\u00e4isenkatu 2, 20520 Turku, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Dentistry, University of Turku, Lemmink\u00e4isenkatu 2, 20520 Turku, Finland","institution_ids":["https://openalex.org/I155660961"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090235761","display_name":"Minna Kangas","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I155660961","display_name":"University of Turku","ror":"https://ror.org/05vghhr25","country_code":"FI","type":"education","lineage":["https://openalex.org/I155660961"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Minna Kangas","raw_affiliation_strings":["Institute of Dentistry, University of Turku, Lemmink\u00e4isenkatu 2, 20520 Turku, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Dentistry, University of Turku, Lemmink\u00e4isenkatu 2, 20520 Turku, Finland","institution_ids":["https://openalex.org/I155660961"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068418092","display_name":"Antti Yli\u2010Urpo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I155660961","display_name":"University of Turku","ror":"https://ror.org/05vghhr25","country_code":"FI","type":"education","lineage":["https://openalex.org/I155660961"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Antti Yli-Urpo","raw_affiliation_strings":["Institute of Dentistry, University of Turku, Lemmink\u00e4isenkatu 2, 20520 Turku, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Dentistry, University of Turku, Lemmink\u00e4isenkatu 2, 20520 Turku, Finland","institution_ids":["https://openalex.org/I155660961"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077411718","display_name":"Juha Kiesvaara","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210118237","display_name":"Orion Corporation (Finland)","ror":"https://ror.org/0296s4x19","country_code":"FI","type":"company","lineage":["https://openalex.org/I4210118237"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Juha Kiesvaara","raw_affiliation_strings":["Pharmaceutical Development Department, Orion Pharma, Orion Corporation, P.O. Box 425, 20101 Turku, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Development Department, Orion Pharma, Orion Corporation, P.O. Box 425, 20101 Turku, Finland","institution_ids":["https://openalex.org/I4210118237"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111768320","display_name":"Martti Marvola","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I133731052","display_name":"University of Helsinki","ror":"https://ror.org/040af2s02","country_code":"FI","type":"education","lineage":["https://openalex.org/I133731052"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Martti Marvola","raw_affiliation_strings":["Division of Biopharmaceutics and Pharmacokinetics, Department of Pharmacy, University of Helsinki, P.O. Box 56, 00014 Helsinki, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Biopharmaceutics and Pharmacokinetics, Department of Pharmacy, University of Helsinki, P.O. Box 56, 00014 Helsinki, Finland","institution_ids":["https://openalex.org/I133731052"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5032586507"],"corresponding_institution_ids":["https://openalex.org/I4210118237"],"apc_list":{"value":4650,"currency":"USD","value_usd":4650},"apc_paid":null,"fwci":2.5708,"has_fulltext":false,"cited_by_count":95,"citation_normalized_percentile":{"value":0.87537862,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"221","issue":"1-2","first_page":"107","last_page":"114"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.40529999136924744,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.40529999136924744,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10735","display_name":"Mesoporous Materials and Catalysis","score":0.30959999561309814,"subfield":{"id":"https://openalex.org/subfields/2505","display_name":"Materials Chemistry"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10343","display_name":"Hydrogels: synthesis, properties, applications","score":0.13660000264644623,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dexmedetomidine","display_name":"dexmedetomidine","score":1.0},{"id":"https://openalex.org/keywords/silica-xerogel","display_name":"silica xerogel","score":0.9440000057220459},{"id":"https://openalex.org/keywords/sol-gel-synthesis","display_name":"sol-gel synthesis","score":0.8240000009536743},{"id":"https://openalex.org/keywords/controlled-drug-release","display_name":"controlled drug release","score":0.8379999995231628},{"id":"https://openalex.org/keywords/diffusion-controlled-release","display_name":"diffusion-controlled release","score":0.7519999742507935},{"id":"https://openalex.org/keywords/isoelectric-point","display_name":"isoelectric point","score":0.8190000057220459},{"id":"https://openalex.org/keywords/ph-effect","display_name":"pH effect","score":0.5180000066757202},{"id":"https://openalex.org/keywords/matrix-degradation","display_name":"matrix degradation","score":0.6669999957084656},{"id":"https://openalex.org/keywords/burst-release","display_name":"burst release","score":0.7760000228881836},{"id":"https://openalex.org/keywords/drug-delivery-devices","display_name":"drug delivery devices","score":0.5879999995231628},{"id":"https://openalex.org/keywords/hydrochloride","display_name":"hydrochloride salts","score":0.7670000195503235}],"concepts":[{"id":"https://openalex.org/C2781302539","wikidata":"https://www.wikidata.org/wiki/Q412133","display_name":"Dexmedetomidine","level":3,"score":0.6061157584190369},{"id":"https://openalex.org/C2778839380","wikidata":"https://www.wikidata.org/wiki/Q278540","display_name":"Alkoxide","level":3,"score":0.5818619132041931},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5372709035873413},{"id":"https://openalex.org/C96294017","wikidata":"https://www.wikidata.org/wiki/Q308708","display_name":"Isoelectric point","level":3,"score":0.5277130007743835},{"id":"https://openalex.org/C106487976","wikidata":"https://www.wikidata.org/wiki/Q685816","display_name":"Matrix (chemical analysis)","level":2,"score":0.46616655588150024},{"id":"https://openalex.org/C38398224","wikidata":"https://www.wikidata.org/wiki/Q48350","display_name":"Sol-gel","level":2,"score":0.45587605237960815},{"id":"https://openalex.org/C2776371256","wikidata":"https://www.wikidata.org/wiki/Q12370","display_name":"Salt (chemistry)","level":2,"score":0.41919511556625366},{"id":"https://openalex.org/C13965031","wikidata":"https://www.wikidata.org/wiki/Q243545","display_name":"Nuclear chemistry","level":1,"score":0.4085431396961212},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.4052391052246094},{"id":"https://openalex.org/C42360764","wikidata":"https://www.wikidata.org/wiki/Q83588","display_name":"Chemical engineering","level":1,"score":0.35017719864845276},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.25941866636276245},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.23509740829467773},{"id":"https://openalex.org/C171250308","wikidata":"https://www.wikidata.org/wiki/Q11468","display_name":"Nanotechnology","level":1,"score":0.1200985312461853},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.05584287643432617},{"id":"https://openalex.org/C2776814716","wikidata":"https://www.wikidata.org/wiki/Q574801","display_name":"Sedation","level":2,"score":0.0},{"id":"https://openalex.org/C161790260","wikidata":"https://www.wikidata.org/wiki/Q82264","display_name":"Catalysis","level":2,"score":0.0},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.0},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.0},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000316","descriptor_name":"Adrenergic alpha-Agonists","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D002626","descriptor_name":"Chemistry, Pharmaceutical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012822","descriptor_name":"Silicon Dioxide","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016503","descriptor_name":"Drug Delivery Systems","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D020927","descriptor_name":"Dexmedetomidine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D058428","descriptor_name":"Silica Gel","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/s0378-5173(01)00656-1","doi":"https://doi.org/10.1016/s0378-5173(01)00656-1","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0378-5173(01)00656-1","pdf_url":null,"source":{"id":"https://openalex.org/S131016564","display_name":"International Journal of Pharmaceutics","issn_l":"0378-5173","issn":["0378-5173","1873-3476"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Pharmaceutics","raw_type":"journal-article"},{"id":"pmid:11397572","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11397572","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International journal of pharmaceutics","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.504800021648407}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":18,"referenced_works":["https://openalex.org/W46236234","https://openalex.org/W205155736","https://openalex.org/W214126376","https://openalex.org/W1990290781","https://openalex.org/W1994670254","https://openalex.org/W1998535733","https://openalex.org/W2001118772","https://openalex.org/W2009841111","https://openalex.org/W2019309327","https://openalex.org/W2024312760","https://openalex.org/W2031092246","https://openalex.org/W2031599049","https://openalex.org/W2048567398","https://openalex.org/W2054032005","https://openalex.org/W2056165869","https://openalex.org/W2071268436","https://openalex.org/W2071431600","https://openalex.org/W2097892579"],"related_works":["https://openalex.org/W2083324577","https://openalex.org/W2037325506","https://openalex.org/W2011769840","https://openalex.org/W2038321847","https://openalex.org/W2019309327","https://openalex.org/W2055237488","https://openalex.org/W2028474762","https://openalex.org/W2080899357","https://openalex.org/W2142234940","https://openalex.org/W6926787881"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":5}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}